NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics

NCT ID: NCT06808503

Last Updated: 2025-02-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-02

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate.

Investigators aim to do the following:

1. Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs).
2. Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Suicide Prevention Suicide

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment As Usual (TAU)

Review all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present.

Group Type NO_INTERVENTION

No interventions assigned to this group

NIMH Clinical Pathway

Implementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up.

Group Type ACTIVE_COMPARATOR

NIMH Clinical Pathway

Intervention Type BEHAVIORAL

Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NIMH Clinical Pathway

Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Youth who are receiving services at the school-based health centers to participate
* Parents must be able to give legal consent for themselves and their children to participate
* Youth and Parent must be English-speaking
* Youth must also be able to give signed assent to participate
* Youth must be cognitively and medically able to participate in study activities

Exclusion Criteria

* Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.
Minimum Eligible Age

12 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West Virginia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mary Christensen

Associate Professor and MSW Program Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mary Christensen, PhD, LICSW

Role: PRINCIPAL_INVESTIGATOR

West Virginia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

West Virginia University

Morgantown, West Virginia, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mary Christensen, PhD, LICSW

Role: CONTACT

304-293-3501

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mary Christensen, PhD, LICSW

Role: primary

304-293-3501

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2405972188

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Suicide Classification System
NCT01118156 COMPLETED
Refinement of Suicide Risk Management Intervention
NCT04888845 ACTIVE_NOT_RECRUITING NA